Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Preclinical assessment of ketamine.

Wang C, Liu F, Patterson TA, Paule MG, Slikker W Jr.

CNS Neurosci Ther. 2013 Jun;19(6):448-53. doi: 10.1111/cns.12079. Epub 2013 Mar 6. Review.

PMID:
23462308
2.

Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.

Wang C, Slikker W Jr.

Anesth Analg. 2008 Jun;106(6):1643-58. doi: 10.1213/ane.ob013e3181732c01. Review.

PMID:
18499593
3.

Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells.

Slikker W Jr, Liu F, Rainosek SW, Patterson TA, Sadovova N, Hanig JP, Paule MG, Wang C.

Mol Neurobiol. 2015 Oct;52(2):959-69. doi: 10.1007/s12035-015-9248-5. Epub 2015 Jun 9.

PMID:
26055230
4.

Use of anesthetic agents in neonates and young children.

Mellon RD, Simone AF, Rappaport BA.

Anesth Analg. 2007 Mar;104(3):509-20. Review.

PMID:
17312200
5.

Utilization of neural stem cell-derived models to study anesthesia-related toxicity and preventative approaches.

Wang C, Liu F, Patterson TA, Paule MG, Slikker W Jr.

Mol Neurobiol. 2013 Oct;48(2):302-7. doi: 10.1007/s12035-013-8501-z. Epub 2013 Jul 12. Review.

PMID:
23846129
6.

Relationship between ketamine-induced developmental neurotoxicity and NMDA receptor-mediated calcium influx in neural stem cell-derived neurons.

Wang C, Liu F, Patterson TA, Paule MG, Slikker W Jr.

Neurotoxicology. 2016 Apr 27. pii: S0161-813X(16)30060-2. doi: 10.1016/j.neuro.2016.04.015. [Epub ahead of print]

PMID:
27132109
7.

Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway.

Bosnjak ZJ, Yan Y, Canfield S, Muravyeva MY, Kikuchi C, Wells CW, Corbett JA, Bai X.

Curr Drug Saf. 2012 Apr;7(2):106-19.

8.

Advanced pre-clinical research approaches and models to studying pediatric anesthetic neurotoxicity.

Wang C.

Front Neurol. 2012 Oct 17;3:142. doi: 10.3389/fneur.2012.00142. eCollection 2012.

10.

Domestic swine model for the assessment of chemical warfare agent-anesthetic interactions: some effects of sulfur mustard.

Conley J, Hunter K, Lundy P, Hamilton M, Sawyer TW.

Mil Med. 2000 Aug;165(8):573-8.

PMID:
10957847
11.

Strategies to defeat ketamine-induced neonatal brain injury.

Turner CP, Gutierrez S, Liu C, Miller L, Chou J, Finucane B, Carnes A, Kim J, Shing E, Haddad T, Phillips A.

Neuroscience. 2012 May 17;210:384-92. doi: 10.1016/j.neuroscience.2012.02.015. Epub 2012 Feb 23.

12.

The role of setting for ketamine abuse: clinical and preclinical evidence.

De Luca MT, Meringolo M, Spagnolo PA, Badiani A.

Rev Neurosci. 2012;23(5-6):769-80. doi: 10.1515/revneuro-2012-0078. Review.

PMID:
23159868
13.

The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture.

Wang C, Sadovova N, Fu X, Schmued L, Scallet A, Hanig J, Slikker W.

Neuroscience. 2005;132(4):967-77.

PMID:
15857702
14.

Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain.

Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, Hanig JP, Paule MG, Slikker W Jr, Wang C.

Int J Dev Neurosci. 2009 Nov;27(7):727-31. doi: 10.1016/j.ijdevneu.2009.06.010. Epub 2009 Jul 4.

PMID:
19580862
15.

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.

Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J.

Behav Brain Res. 2011 Aug 1;221(1):166-71. doi: 10.1016/j.bbr.2011.02.024. Epub 2011 Mar 21.

PMID:
21397634
16.

Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain.

Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, Labruyere J, Olney JW.

Br J Pharmacol. 2005 Sep;146(2):189-97.

17.

Treatment of status epilepticus with ketamine, are we there yet?

Dorandeu F, Dhote F, Barbier L, Baccus B, Testylier G.

CNS Neurosci Ther. 2013 Jun;19(6):411-27. doi: 10.1111/cns.12096. Epub 2013 Apr 20. Review.

PMID:
23601960
18.

Effects of combined ketamine/xylazine anesthesia on light induced retinal degeneration in rats.

Arango-Gonzalez B, Schatz A, Bolz S, Eslava-Schmalbach J, Willmann G, Zhour A, Zrenner E, Fischer MD, Gekeler F.

PLoS One. 2012;7(4):e35687. doi: 10.1371/journal.pone.0035687. Epub 2012 Apr 25. Erratum in: PLoS One. 2012;7(8). doi:10.1371/annotation/d52a610e-6a56-4158-90bf-45e37f053567.

19.

Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

Mion G, Villevieille T.

CNS Neurosci Ther. 2013 Jun;19(6):370-80. doi: 10.1111/cns.12099. Epub 2013 Apr 10.

PMID:
23575437
20.

Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons.

Scallet AC, Schmued LC, Slikker W Jr, Grunberg N, Faustino PJ, Davis H, Lester D, Pine PS, Sistare F, Hanig JP.

Toxicol Sci. 2004 Oct;81(2):364-70. Epub 2004 Jul 14.

Items per page

Supplemental Content

Write to the Help Desk